• bitcoinBitcoin(BTC)$80,263.00-0.17%
  • ethereumEthereum(ETH)$2,328.14-0.19%
  • tetherTether(USDT)$1.000.02%
  • binancecoinBNB(BNB)$741.200.02%
  • rippleXRP(XRP)$1.29-0.19%
  • usd-coinUSDC(USDC)$1.000.02%
  • solanaSolana(SOL)$101.590.73%
  • tronTRON(TRX)$0.3302860.38%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.000.00%
  • zcashZcash(ZEC)$1,230.091.92%
  • HyperliquidHyperliquid(HYPE)$77.361.24%
  • dogecoinDogecoin(DOGE)$0.0771600.79%
  • moneroMonero(XMR)$590.85-2.07%
  • USDSUSDS(USDS)$1.00-0.01%
  • whitebitWhiteBIT Coin(WBT)$77.31-0.19%
  • chainlinkChainlink(LINK)$11.450.69%
  • leo-tokenLEO Token(LEO)$8.97-0.46%
  • cardanoCardano(ADA)$0.2045880.17%
  • stellarStellar(XLM)$0.1697390.39%
  • nearNEAR Protocol(NEAR)$4.562.19%
  • RainRain(RAIN)$0.008083-0.17%
  • bitcoin-cashBitcoin Cash(BCH)$279.462.44%
  • Ethena USDeEthena USDe(USDE)$1.00-0.04%
  • daiDai(DAI)$1.000.02%
  • litecoinLitecoin(LTC)$56.620.52%
  • uniswapUniswap(UNI)$7.044.64%
  • CantonCanton(CC)$0.1006760.08%
  • avalanche-2Avalanche(AVAX)$8.951.49%
  • USD1USD1(USD1)$1.00-0.02%
  • suiSui(SUI)$0.92-0.05%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.22-2.41%
  • hedera-hashgraphHedera(HBAR)$0.0773770.92%
  • tether-goldTether Gold(XAUT)$4,015.640.70%
  • quant-networkQuant(QNT)$218.5520.53%
  • Global DollarGlobal Dollar(USDG)$1.000.00%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.05%
  • shiba-inuShiba Inu(SHIB)$0.000005-0.14%
  • BittensorBittensor(TAO)$252.111.47%
  • EthenaEthena(ENA)$0.2055915.21%
  • crypto-com-chainCronos(CRO)$0.054122-0.78%
  • Ripple USDRipple USD(RLUSD)$1.000.00%
  • Circle USYCCircle USYC(USYC)$1.140.00%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.15-0.05%
  • okbOKB(OKB)$108.871.98%
  • MemeCoreMemeCore(M)$1.009.15%
  • BitwayBitway(BTW)$1.49-12.66%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • aaveAave(AAVE)$135.83-0.22%
  • OndoOndo(ONDO)$0.4126272.52%
  • Pump.funPump.fun(PUMP)$0.0042591.35%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Halozyme Therapeutics: Running Through 2027 (NASDAQ:HALO)

August 24, 2026
in Market & News
Reading Time: 3 mins read
A A
Halozyme Therapeutics: Running Through 2027 (NASDAQ:HALO)
ShareShareShareShareShare

This article was written by

YOU MAY ALSO LIKE

Doctor says Pope Leo’s cancer likely ‘early stage’

Vatican announces that Pope Leo has lung cancer

I’ve been investing for almost 10 years with a focus on long term wealth creation through value growth investing, value investing, and dividend investing. I’m not a financial advisor or financial planner. I do not have a formal background in finance, I have a B.S. in Biology with a concentration in molecular cell biology. I am an avid reader, studier, and learner and have applied my rigorous undergraduate studies and research to investing. I plan to write articles on companies through the lens of fundamental value investing and attempt to find great companies at fair prices. All articles or comments are based on my personal experience, my own research, books/articles I’ve read, or general ideas about building long term wealth.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of HALO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

I’m not an investment professional or investment advisor. This article is solely based on my own opinions and research. This is not meant to be a recommendation of the sale or the purchase of any securities. The investments or strategies discussed within this article are of my own personal opinions and commentary. This article has been written for educational and research purposes only. This article does not consider the reader’s financial situation, investment goals, needs, or any other personal circumstances. Investors should conduct their own research and perform their own due diligence before making any investment decisions.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Credit: Source link

ShareTweetSendSharePin

Related Posts

Doctor says Pope Leo’s cancer likely ‘early stage’
Market & News

Doctor says Pope Leo’s cancer likely ‘early stage’

October 26, 2026
Vatican announces that Pope Leo has lung cancer
Market & News

Vatican announces that Pope Leo has lung cancer

October 26, 2026
Doctor says Pope Leo has ‘one of the more treatable’ cancers
Market & News

Doctor says Pope Leo has ‘one of the more treatable’ cancers

October 26, 2026
Affording America: How a Nebraska family struggles to make ends meet
Market & News

Affording America: How a Nebraska family struggles to make ends meet

October 26, 2026
Next Post
ICE purchases ‘zap gloves’ to use on non-compliant suspects

ICE purchases ‘zap gloves’ to use on non-compliant suspects

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Macron slams foreign leaders’ France protest comments

Macron slams foreign leaders’ France protest comments

October 22, 2026
Oregon shooter entered school by shooting at locked doors

Oregon shooter entered school by shooting at locked doors

October 24, 2026
Trump says he will have final say in fraud incentive program payouts

Trump says he will have final say in fraud incentive program payouts

October 22, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!